Robert E. Landry, EVP Finance CFO at REGENERON PHARMACEUTICALS, INC. (REGN), sold 2,500 shares at $756.50 ($1.9M) on 2022-12-02, disclosed to the SEC on 2022-12-02.
Seasonal sale ($1.9M) by EVP Finance CFO — this insider has traded REGN in December in at least three consecutive prior years. Pattern-driven, low signal.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $760.35 | 1,890 | $1.4M | 75.7% |
| 2 | $756.50 | 582 | $440K | 23.2% |
| 3 | $759.90 | 16 | $12K | 0.6% |
| 4 | $760.19 | 12 | $9K | 0.5% |
| Total | $759.45 avg | 2,500 | $1.9M | 100% |
| Filing → |
| REGN | SELL | 2023-08-25 | $188K | — | Filing → |
| REGN | SELL | 2023-03-29 | $1.8M | — | Filing → |
| REGN | SELL | 2023-02-07 | $2.1M | — | Filing → |